LOCT WALK Chart calendar LOCT WALK
528bea4074fdcc2.TjN8bOt2bjLgAuitjoh9bRMKePnp7-1BhtEWTWXxXn0.BVAkO7sTJ3SMV9nMve1FD3BzOY6ajpsCvqd9fRe1LDUGcQU-ohkAQc12rQ~073f8e10a2df9caf026d534cb401b00f
Upcoming events on LOCT WALK
Past events on LOCT WALK
| 2024-06-13 04:00 pm | Annual General Meeting |
| 2024-05-09 04:01 pm | Q1 2024 Earnings Release |
| 2024-04-16 11:30 am | Stifel Virtual Targeted Oncology Days Conference |
| 2024-03-25 04:01 pm | Q4 2023 Earnings Release |
| 2024-03-15 10:00 am | Investor Meeting - Stifel |
| 2024-02-14 10:40 am | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-24 04:30 pm | R&D Day |
| 2024-01-07 | Investor Meeting |
| 2023-12-08 01:00 pm | San Antonio Breast Cancer Symposium |
| 2023-11-15 12:40 pm | Stifel Healthcare Conference |
| 2023-11-13 04:14 pm | Q3 2023 Earnings Release |
| 2023-09-26 03:00 pm | Cantor Global Healthcare Conference |
| 2023-09-13 10:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-08 04:01 pm | Q2 2023 Earnings Release |
| 2023-06-22 04:00 pm | Annual General Meeting |
| 2023-06-04 07:30 pm | American Society of Clinical Oncology Conference |
| 2023-06-04 09:00 am | American Society of Clinical Oncology Conference - Abstract No: 1080 |
| 2023-05-15 09:30 am | JMP Securities Life Sciences Conference |
| 2023-05-08 | Q1 2023 Earnings Release |
| 2023-04-25 02:00 pm | Stifel Targeted Oncology Days |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 1,43 1,21 18.01% | 3,55 3,55 0.04% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -31,9 -27,9 -14.36% | -32,4 -36,0 10.19% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -31,9 -29,9 -6.56% | -32,4 -34,2 5.25% | -33,8 -32,2 -4.96% | -32,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 15,8 -11,0 243.44% | -22,7 -23,9 5.14% | -35,8 -34,2 -4.75% | -34,6 |
|
Net income Million USD | Released Forecast Spread | 0,17 | 15,8 -11,0 243.44% | -22,7 -23,8 4.83% | -35,8 -34,2 -4.77% | -34,6 |
|
EPS USD | Released Forecast Spread | 0,25 | 11,0 -10,2 208.37% | -13,8 -14,3 3.51% | -16,4 -15,6 -4.97% | -6,17 |
| Announcement Date | 14/06/21 | 16/03/22 | 08/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,35 - | 2,01 0,53 283.05% | 0,87 0,64 35.05% | 0,67 0,66 1.51% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -6,55 -11,5 42.89% | -7,88 -7,79 -1.2% | -9,25 -10,2 8.86% | -8,72 -10,5 16.98% | -9,54 -8,32 -14.66% | -7,86 -8,66 9.33% | -7,86 -7,73 -1.64% | -8,60 -7,02 -22.44% | -8,40 -8,53 1.52% | -8,40 | -8,20 | -7,80 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,07 -11,0 127.82% | -6,92 -7,61 9.08% | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,83 -8,90 0.75% | -8,80 | -8,70 | -8,30 |
|
Net income Million USD | Released Forecast Spread | 3,07 -11,0 127.82% | -6,92 -7,61 9.08% | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,83 -8,90 0.75% | -8,80 | -8,70 | -8,30 |
|
EPS USD | Released Forecast Spread | 1,75 -5,95 129.41% | -4,25 -4,05 -4.94% | -5,75 -5,35 -7.48% | -5,50 -5,95 7.56% | -6,00 -3,38 -77.78% | -4,25 -4,94 13.92% | -3,25 -3,08 -5.41% | -3,42 -2,73 -25.27% | -2,16 -2,17 0.23% | -2,02 | -1,95 | -0,87 |
| Announcement Date | 10/05/22 | 09/08/22 | 07/11/22 | 08/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 26/03/24 | 09/05/24 | - | - | - |
